ESC Professional Premium Access

Pathomechanisms and treatment of valve disease

Event: ESC Congress 2022
Topic: Valvular Heart Disease
Session type: Moderated ePosters
Date: 29 August 2022
Time: 16:15 - 16:55

Congress Session

6 presentations in this session

Loss of ceramide synthase 5 reduces the development of aortic valve stenosis in mice with high fat diet.

Speaker: Ms L. Reese (Bonn, DE)

Non-vitamin K antagonist oral anticoagulants (NOACs) attenuate valvular calcification in patients with severe aortic stenosis

Speaker: Ms M. Kopytek (Krakow, PL)

Unravelling the role of SOCS3 in aortic valve stenosis

Speaker: Doctor H. Billig (Bonn, DE)

Specific gene domains most commonly affected by CHIP-driver mutations predicting mortality in severe aortic stenosis after transcatheter aortic valve implantation

Speaker: Associate Professor S. Mas-Peiro (Frankfurt, DE)

Histology-verified myocardial fibrosis and quantification in severe AS patients: correlation with non-invasive LV myocardial tissue assessment

Speaker: Doctor S. Maltes (Lisbon, PT)

Autologous or bovine pericardium for aortic cusp replacement? Histomorphological and biomechanical properties as decision making tools

Speaker: Doctor C. Dittfeld (Dresden, DE)

6 speakers from this session

Ms Laurine Reese

University hospital Bonn, Bonn (Germany)
0 follower

Ms Magdalena Kopytek

John Paul II Hospital, Krakow (Poland)
0 follower

Doctor Hannah Billig

Heartcenter Bonn, University Hospital Bonn, Bonn (Germany)
0 follower

Associate Professor Silvia Mas-Peiro

Wolfgang Goethe University, Frankfurt (Germany)
1 presentation
0 follower

Doctor Sergio Maltes

Hospital Santa Cruz, Lisbon (Portugal)
0 follower

Doctor Claudia Dittfeld

Dresden University Of Technology, Dresden (Germany)
0 follower

This platform is supported by

logo Novo Nordisk